Q. Zhang

Statistics

Publications

Citations

H-Index

Active since

2016

Affiliations

Q. Zhang is an author at Eli Lilly (United States) specializing in clinical pharmacology, pharmacovigilance, and calcitonin gene-related peptide monoclonal antibodies.

ORCID

Publications per year

2016–2019

Publications

Positive response to galcanezumab following treatment failure to onabotulinumtoxinA in patients with migraine: <i>post hoc</i> analyses of three randomized double‐blind studies

Jessica Ailani, Eric Pearlman, Q. Zhang et al. · European Journal of Neurology · 2019 · 26 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Similar <scp>HbA1c</scp> reduction and hypoglycaemia with variable‐ vs fixed‐time dosing of basal insulin peglispro in type 1 diabetes: <scp>IMAGINE</scp> 7 study

Satish K. Garg, J. L. Selam, Anuj Bhargava et al. · Diabetes Obesity and Metabolism · 2016 · 11 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–2 of 2